{"id":"https://openalex.org/W2001542004","doi":"https://doi.org/10.1089/cap.2013.0103","title":"Guanfacine Extended Release Adjunctive to a Psychostimulant in the Treatment of Comorbid Oppositional Symptoms in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder","display_name":"Guanfacine Extended Release Adjunctive to a Psychostimulant in the Treatment of Comorbid Oppositional Symptoms in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder","publication_year":2014,"publication_date":"2014-06-01","ids":{"openalex":"https://openalex.org/W2001542004","doi":"https://doi.org/10.1089/cap.2013.0103","mag":"2001542004","pmid":"https://pubmed.ncbi.nlm.nih.gov/24945085","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4064735"},"language":"en","primary_location":{"id":"doi:10.1089/cap.2013.0103","doi":"https://doi.org/10.1089/cap.2013.0103","is_oa":false,"landing_page_url":"https://doi.org/10.1089/cap.2013.0103","pdf_url":null,"source":{"id":"https://openalex.org/S198272637","display_name":"Journal of Child and Adolescent Psychopharmacology","issn_l":"1044-5463","issn":["1044-5463","1557-8992"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Child and Adolescent Psychopharmacology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4064735","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5042787535","display_name":"Robert L. Findling","orcid":"https://orcid.org/0000-0002-7654-5782","observed_orcids":["https://orcid.org/0000-0002-7654-5782"]},"institutions":[{"id":"https://openalex.org/I1298154867","display_name":"Kennedy Krieger Institute","ror":"https://ror.org/05q6tgt32","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1298154867"]},{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Robert L. Findling","raw_affiliation_strings":["Department of Psychiatry, Johns Hopkins University and the Kennedy Krieger Institute, Baltimore, Maryland","1 Department of Psychiatry, Johns Hopkins University and the Kennedy Krieger Institute , Baltimore, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, Johns Hopkins University and the Kennedy Krieger Institute, Baltimore, Maryland","institution_ids":["https://openalex.org/I1298154867","https://openalex.org/I145311948"]},{"raw_affiliation_string":"1 Department of Psychiatry, Johns Hopkins University and the Kennedy Krieger Institute , Baltimore, Maryland","institution_ids":["https://openalex.org/I1298154867","https://openalex.org/I145311948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068382742","display_name":"Keith McBurnett","orcid":"https://orcid.org/0000-0001-7327-2435","observed_orcids":["https://orcid.org/0000-0001-7327-2435"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Keith McBurnett","raw_affiliation_strings":["University of California-San Francisco, San Francisco, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California-San Francisco, San Francisco, California","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111836698","display_name":"Carla White","orcid":"https://orcid.org/0009-0006-5309-1761","observed_orcids":["https://orcid.org/0009-0006-5309-1761"]},"institutions":[{"id":"https://openalex.org/I4387155342","display_name":"Shire (United Kingdom)","ror":"https://ror.org/0547dck29","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210147578","https://openalex.org/I4387155342","https://openalex.org/I44892455"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Carla White","raw_affiliation_strings":["Shire Decessed. At the time of writing, Basingstoke, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Shire Decessed. At the time of writing, Basingstoke, United Kingdom","institution_ids":["https://openalex.org/I4387155342"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5014498002","display_name":"Sharon H. Youcha","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I72816309","display_name":"Drexel University","ror":"https://ror.org/04bdffz58","country_code":"US","type":"education","lineage":["https://openalex.org/I72816309"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sharon Youcha","raw_affiliation_strings":["Drexel University College of Medicine, Philadelphia, Pennsylvania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drexel University College of Medicine, Philadelphia, Pennsylvania","institution_ids":["https://openalex.org/I72816309"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5042787535"],"corresponding_institution_ids":["https://openalex.org/I1298154867","https://openalex.org/I145311948"],"apc_list":null,"apc_paid":null,"fwci":3.5621,"has_fulltext":false,"cited_by_count":32,"citation_normalized_percentile":{"value":0.91882998,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"24","issue":"5","first_page":"245","last_page":"252"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10537","display_name":"Attention Deficit Hyperactivity Disorder","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10537","display_name":"Attention Deficit Hyperactivity Disorder","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10826","display_name":"Behavioral and Psychological Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3204","display_name":"Developmental and Educational Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/guanfacine-extended-release","display_name":"guanfacine extended release","score":0.996999979019165},{"id":"https://openalex.org/keywords/attention-deficit-hyperactivity-disorder","display_name":"attention deficit hyperactivity disorder","score":0.9559999704360962},{"id":"https://openalex.org/keywords/psychostimulants","display_name":"psychostimulants","score":0.8220000267028809},{"id":"https://openalex.org/keywords/adjunctive-therapy","display_name":"adjunctive therapy","score":0.8320000171661377},{"id":"https://openalex.org/keywords/children-and-adolescents","display_name":"children and adolescents","score":0.8840000033378601},{"id":"https://openalex.org/keywords/dose-optimization","display_name":"dose optimization","score":0.5360000133514404},{"id":"https://openalex.org/keywords/treatment-emergent-adverse-events","display_name":"treatment-emergent adverse events","score":0.8889999985694885}],"concepts":[{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.7100186347961426},{"id":"https://openalex.org/C2780783007","wikidata":"https://www.wikidata.org/wiki/Q181923","display_name":"Attention deficit hyperactivity disorder","level":2,"score":0.6202371120452881},{"id":"https://openalex.org/C2780815205","wikidata":"https://www.wikidata.org/wiki/Q5613599","display_name":"Guanfacine","level":3,"score":0.5957089066505432},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5274505615234375},{"id":"https://openalex.org/C2777112843","wikidata":"https://www.wikidata.org/wiki/Q422112","display_name":"Methylphenidate","level":3,"score":0.5114752054214478},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.506409764289856},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.5029603838920593},{"id":"https://openalex.org/C3018162438","wikidata":"https://www.wikidata.org/wiki/Q1304270","display_name":"Adjunctive treatment","level":2,"score":0.4669913351535797},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.4603009819984436},{"id":"https://openalex.org/C83849319","wikidata":"https://www.wikidata.org/wiki/Q7295720","display_name":"Rating scale","level":2,"score":0.4516604542732239},{"id":"https://openalex.org/C2776476923","wikidata":"https://www.wikidata.org/wiki/Q7725","display_name":"Evening","level":2,"score":0.4440218210220337},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.344387024641037},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.23307418823242188},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2284110188484192},{"id":"https://openalex.org/C138496976","wikidata":"https://www.wikidata.org/wiki/Q175002","display_name":"Developmental psychology","level":1,"score":0.09816786646842957},{"id":"https://openalex.org/C1276947","wikidata":"https://www.wikidata.org/wiki/Q333","display_name":"Astronomy","level":1,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C2778399450","wikidata":"https://www.wikidata.org/wiki/Q412221","display_name":"Clonidine","level":2,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000697","descriptor_name":"Central Nervous System Stimulants","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000697","descriptor_name":"Central Nervous System Stimulants","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001289","descriptor_name":"Attention Deficit Disorder with Hyperactivity","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D001289","descriptor_name":"Attention Deficit Disorder with Hyperactivity","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001289","descriptor_name":"Attention Deficit Disorder with Hyperactivity","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D002648","descriptor_name":"Child","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003692","descriptor_name":"Delayed-Action Preparations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011569","descriptor_name":"Psychiatric Status Rating Scales","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012720","descriptor_name":"Severity of Illness Index","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016316","descriptor_name":"Guanfacine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D016316","descriptor_name":"Guanfacine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D019958","descriptor_name":"Attention Deficit and Disruptive Behavior Disorders","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D019958","descriptor_name":"Attention Deficit and Disruptive Behavior Disorders","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D019958","descriptor_name":"Attention Deficit and Disruptive Behavior Disorders","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D058647","descriptor_name":"Adrenergic alpha-2 Receptor Agonists","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D058647","descriptor_name":"Adrenergic alpha-2 Receptor Agonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1089/cap.2013.0103","doi":"https://doi.org/10.1089/cap.2013.0103","is_oa":false,"landing_page_url":"https://doi.org/10.1089/cap.2013.0103","pdf_url":null,"source":{"id":"https://openalex.org/S198272637","display_name":"Journal of Child and Adolescent Psychopharmacology","issn_l":"1044-5463","issn":["1044-5463","1557-8992"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Child and Adolescent Psychopharmacology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:4064735","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4064735","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Child Adolesc Psychopharmacol","raw_type":"Text"},{"id":"pmid:24945085","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24945085","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of child and adolescent psychopharmacology","raw_type":"Comparative Study"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:4064735","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4064735","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Child Adolesc Psychopharmacol","raw_type":"Text"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":29,"referenced_works":["https://openalex.org/W107618943","https://openalex.org/W1974753535","https://openalex.org/W1984691385","https://openalex.org/W1992746426","https://openalex.org/W1999197123","https://openalex.org/W2002134787","https://openalex.org/W2009495567","https://openalex.org/W2010675100","https://openalex.org/W2021898155","https://openalex.org/W2022741651","https://openalex.org/W2023323019","https://openalex.org/W2033903112","https://openalex.org/W2039762616","https://openalex.org/W2048092855","https://openalex.org/W2060198969","https://openalex.org/W2066273571","https://openalex.org/W2066906758","https://openalex.org/W2080494105","https://openalex.org/W2082765847","https://openalex.org/W2108685959","https://openalex.org/W2117095140","https://openalex.org/W2134421313","https://openalex.org/W2159337254","https://openalex.org/W2159859720","https://openalex.org/W2164549762","https://openalex.org/W2167062019","https://openalex.org/W2584452351","https://openalex.org/W4237214904","https://openalex.org/W4321429195"],"related_works":["https://openalex.org/W107618943","https://openalex.org/W2012103462","https://openalex.org/W2036512573","https://openalex.org/W2134421313","https://openalex.org/W3028402039","https://openalex.org/W2159337254","https://openalex.org/W2081135371","https://openalex.org/W2784250746","https://openalex.org/W7100804827","https://openalex.org/W2112229136"],"abstract_inverted_index":{"OBJECTIVE:":[0],"The":[1],"purpose":[2],"of":[3,11,38,75,92,117,144,191,216],"this":[4],"study":[5,37,162,231],"was":[6,53,67],"to":[7,17,51,62,135,172,236,257],"assess":[8],"the":[9,114,118,136,141,145,160,173,189,219,229],"effect":[10],"guanfacine":[12],"extended":[13],"release":[14],"(GXR)":[15],"adjunctive":[16,50,235],"a":[18,72,237,247,254],"psychostimulant":[19,52,63,76,152,238,248,258],"on":[20,140],"oppositional":[21,115,142,196,241],"symptoms":[22,197,242],"in":[23,55,159,188,218,228,249],"children":[24],"and":[25,88,103,214,224,253],"adolescents":[26],"with":[27,59,71,80,149,154,193,244,251],"attention-deficit/hyperactivity":[28],"disorder":[29],"(ADHD).":[30],"METHODS:":[31],"A":[32],"multicenter,":[33],"double-blind,":[34],"placebo-controlled":[35],"dose-optimization":[36],"GXR":[39,150,177,181,202,220,222,234],"(1-4":[40],"mg/d)":[41],"or":[42,47],"placebo":[43,155,225,245],"administered":[44],"morning":[45],"(a.m.)":[46],"evening":[48],"(p.m.)":[49],"conducted":[54],"subjects":[56,192,217,250],"ages":[57],"6-17":[58],"suboptimal":[60,255],"response":[61,66,256],"alone.":[64,259],"Suboptimal":[65],"defined":[68],"as":[69,96,98,185,187],"treatment":[70],"stable":[73],"dose":[74],"for":[77],"\u22654":[78],"weeks":[79],"ADHD":[81,252],"Rating":[82,121],"Scale":[83],"IV":[84],"total":[85],"score":[86,94],"\u226524":[87],"Clinical":[89],"Global":[90],"Impressions-Severity":[91],"Illness":[93],"\u22653,":[95],"well":[97,186],"investigator":[99],"opinion.":[100],"Primary":[101],"efficacy":[102,111],"safety":[104],"results":[105],"have":[106],"been":[107],"reported":[108,128,210],"previously.":[109],"Secondary":[110],"measures":[112],"included":[113],"subscale":[116,143],"Conners'":[119],"Parent":[120],"Scale-Revised:":[122],"Long":[123],"Form":[124],"(CPRS-R:L);":[125],"these":[126],"are":[127],"herein.":[129],"RESULTS:":[130],"Significant":[131],"reductions":[132],"from":[133,170],"baseline":[134,171,195],"final":[137,174],"on-treatment":[138,175],"assessment":[139],"CPRS-R:L":[146],"were":[147,209],"seen":[148],"plus":[151,156,246],"compared":[153,243],"psychostimulant,":[157],"both":[158],"overall":[161,230],"population":[163],"(placebo-adjusted":[164],"least":[165],"squares":[166],"[LS]":[167],"mean":[168],"change":[169],"assessment:":[176],"a.m.+psychostimulant,":[178,199],"-2.4,":[179],"p=0.001;":[180,201],"p.m.+psychostimulant,":[182,203],"-2.2,":[183],"p=0.003)":[184],"subgroup":[190],"significant":[194],"(GXR":[198],"-3.6,":[200],"-2.7,":[204],"p=0.013).":[205],"Treatment-emergent":[206],"adverse":[207],"events":[208],"by":[211],"77.3%,":[212],"76.3%,":[213],"63.4%":[215],"a.m.,":[221],"p.m.,":[223],"groups,":[226],"respectively,":[227],"population.":[232],"CONCLUSIONS:":[233],"significantly":[239],"reduced":[240]},"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":7}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}